Biotechnology
/

Orthogenics AS
Osteoarthritis diagnostics & treatment

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 74
    Operating profit:-3.227
    Operating profit before tax: -3.479
    Total assets: 12.167
    Total equity: 5.948
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Finn Olav Rusti Elde

    Board Members:
    Bjørn Thorkildsen
    Erik Anders Lønneborg
    Oddvar Sæther
    Olav Flaten
    Ole Petter Gilbo

    General Manager:
    Stein Lian

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biotechnology, Health Care, Pharmaceutical & Medical Chemical Products, Research and experimental development services,